149 related articles for article (PubMed ID: 30373260)
1. Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity.
Žula A; Będziak I; Kikelj D; Ilaš J
Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373260
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
[TBL] [Abstract][Full Text] [Related]
3. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
4. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
5. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
[TBL] [Abstract][Full Text] [Related]
6. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
Wang G; Goyal N; Hopkinson B
Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
[TBL] [Abstract][Full Text] [Related]
7. Amino acids and peptides. XVIII. Synthetic peptides related to N-terminal portion of fibrin alpha-chain and their inhibitory effect on fibrinogen/thrombin clotting.
Kawasaki K; Miyano M; Hirase K; Iwamoto M
Chem Pharm Bull (Tokyo); 1993 May; 41(5):975-7. PubMed ID: 8339344
[TBL] [Abstract][Full Text] [Related]
8. A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain.
De Marco R; Di Gioia ML; Leggio A; Liguori A; Perri F; Siciliano C; Viscomi MC
Amino Acids; 2010 Mar; 38(3):691-700. PubMed ID: 19283444
[TBL] [Abstract][Full Text] [Related]
9. Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
Kawasaki K; Hirase K; Miyano M; Tsuji T; Iwamoto M
Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3253-60. PubMed ID: 1294328
[TBL] [Abstract][Full Text] [Related]
10. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
Jetten M; Peters CA; Visser A; Grootenhuis PD; van Nispen JW; Ottenheijm HC
Bioorg Med Chem; 1995 Aug; 3(8):1099-114. PubMed ID: 7582983
[TBL] [Abstract][Full Text] [Related]
11. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
Radau G; Stürzebecher J
Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
[TBL] [Abstract][Full Text] [Related]
12. The non-ribosomal assembly and frequent occurrence of the protease inhibitors spumigins in the bloom-forming cyanobacterium Nodularia spumigena.
Fewer DP; Jokela J; Rouhiainen L; Wahlsten M; Koskenniemi K; Stal LJ; Sivonen K
Mol Microbiol; 2009 Sep; 73(5):924-37. PubMed ID: 19691450
[TBL] [Abstract][Full Text] [Related]
13. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals. New orally active stable analogs of D-Phe-Pro-Arg-H.
Bajusz S; Barabás E; Fauszt I; Fehér A; Horváth G; Juhász A; Szabó AG; Széll E
Bioorg Med Chem; 1995 Aug; 3(8):1079-89. PubMed ID: 7582981
[TBL] [Abstract][Full Text] [Related]
14. Thrombin inhibitors from the freshwater cyanobacterium Anabaena compacta.
Anas AR; Kisugi T; Umezawa T; Matsuda F; Campitelli MR; Quinn RJ; Okino T
J Nat Prod; 2012 Sep; 75(9):1546-52. PubMed ID: 22950366
[TBL] [Abstract][Full Text] [Related]
15. New proline mimetics: synthesis of thrombin inhibitors incorporating cyclopentane- and cyclopentenedicarboxylic acid templates in the P2 position. Binding conformation investigated by X-ray crystallography.
Nöteberg D; Brånalt J; Kvarnström I; Linschoten M; Musil D; Nyström JE; Zuccarello G; Samuelsson B
J Med Chem; 2000 May; 43(9):1705-13. PubMed ID: 10794688
[TBL] [Abstract][Full Text] [Related]
16. Pseudoaeruginosins, nonribosomal peptides in Nodularia spumigena.
Liu L; Budnjo A; Jokela J; Haug BE; Fewer DP; Wahlsten M; Rouhiainen L; Permi P; Fossen T; Sivonen K
ACS Chem Biol; 2015 Mar; 10(3):725-33. PubMed ID: 25419633
[TBL] [Abstract][Full Text] [Related]
17. Highly selective tripeptide thrombin inhibitors.
Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Gesellchen PD
J Med Chem; 1993 Feb; 36(3):314-9. PubMed ID: 8426361
[TBL] [Abstract][Full Text] [Related]
18. Design of selective thrombin inhibitors based on the (R)-Phe-Pro-Arg sequence.
Danilewicz JC; Abel SM; Brown AD; Fish PV; Hawkeswood E; Holland SJ; James K; McElroy AB; Overington J; Powling MJ; Rance DJ
J Med Chem; 2002 Jun; 45(12):2432-53. PubMed ID: 12036353
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity.
de Candia M; Fiorella F; Lopopolo G; Carotti A; Romano MR; Lograno MD; Martel S; Carrupt PA; Belviso BD; Caliandro R; Altomare C
J Med Chem; 2013 Nov; 56(21):8696-711. PubMed ID: 24102612
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
Girnys EA; Sobczyk-Kojiro K; Mosberg HI
Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
